Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey
Neal Hermanowicz,1 Michelle Castillo-Shell,2 Angela McMean,3 Jesse Fishman,2 Joseph D’Souza21Movement Disorders Program and Department of Neurology, University of California-Irvine, Irvine, CA, USA; 2UCB Pharma, Smyrna, GA, USA; 3Ashfield Insight & Performance, part of Ashfield Hea...
Guardado en:
Autores principales: | Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D’Souza J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/771ed9f70086421f9562f82821dffd9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Parkinson's disease
-
Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
por: Mao CJ, et al.
Publicado: (2017) -
Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino C, et al.
Publicado: (2016) -
The role of rasagiline in the treatment of Parkinson’s disease
por: Julie Leegwater-Kim, et al.
Publicado: (2010) -
Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)